HCG / Human Chorionic Gonadotropin
Human chorionic gonadotropin, commonly abbreviated as hCG, is a glycoprotein hormone composed of two non-covalently linked subunits: an alpha subunit and a beta subunit. The alpha subunit contains 92 amino acids and is shared with other glycoprotein hormones such as LH, FSH, and TSH, while the beta subunit contains 145 amino acids and contributes to the hormone-specific biological identity of hCG.
hCG is studied primarily through its interaction with the luteinizing hormone/choriogonadotropin receptor, known as LHCGR. This receptor is a G-protein-coupled receptor involved in reproductive endocrinology, steroidogenesis, gonadal signaling, placental biology, and pregnancy-related research. Literature comparing LH and hCG suggests that although both hormones act through the same receptor, they may produce distinct signaling patterns, including differences in receptor binding, intracellular signaling, and biological response.
Specifications
Structure: Heterodimeric glycoprotein hormone
Alpha Subunit: 92 amino acids
Beta Subunit: 145 amino acids
Approximate Molecular Weight: variable due to glycosylation; commonly reported around 36–40 kDa depending on form and assay method
Primary Research Target: LH/CG receptor / LHCGR
Compound Class: Glycoprotein hormone
HCG Research
HCG and LHCGR Signaling
hCG binds to the LH/CG receptor, a receptor involved in gonadal and reproductive endocrine signaling. Structural research suggests that hCG binding involves high-affinity interaction with the receptor’s extracellular region, followed by conformational changes that support receptor activation.
HCG and Reproductive Endocrinology Research
hCG has long been studied for its role in pregnancy biology, placental signaling, ovarian steroidogenesis, corpus luteum maintenance, implantation-related pathways, and fetal-development research. Reviews describe hCG as predominantly active in pregnancy and fetal-development contexts, while LH is more directly associated with ovulation and gonadal steroidogenesis.
HCG and Biased Agonism Research
Although LH and hCG activate the same receptor, research suggests they may not be biologically identical. Reviews describe hormone-specific receptor binding and intracellular signaling cascades, meaning hCG and LH can show different signal intensity, duration, and pathway preference at the LHCGR. This concept is sometimes referred to as biased agonism and is an active area of receptor-signaling research.
References
Lustbader JW, et al. Characterization of the expression products of recombinant human choriogonadotropin and its subunits. Biochemistry. 1987.
Choi J, Smitz J. Luteinizing hormone and human chorionic gonadotropin: origins of difference. Mol Cell Endocrinol. 2014.
Casarini L, et al. Two hormones for one receptor: evolution, biochemistry, actions, and pathophysiology of LH and hCG. Endocr Rev. 2018.
Ryu KS, et al. Molecular mechanism of LH/CG receptor activation. Mol Endocrinol. 1996.
Disclaimer: This product is not intended for human or animal consumption. Research chemicals are intended solely for laboratory experimentation and/or in-vitro testing. Bodily introduction of any sort is strictly prohibited. All information shared here is for educational and research-reference purposes only.